Lead Phytochemicals for Anticancer Drug Development

Area of Science:

• Pharmacology and Drug Discovery
• Natural Product Chemistry
• Oncology

Background:

• Cancer remains a leading cause of mortality despite existing treatments.
• There is a critical need for novel anticancer therapies with improved efficacy and reduced side effects.
• Phytochemicals, compounds from plants, are emerging as promising candidates for cancer treatment due to their targeted action.

Approach:

• This review explores lead phytomolecules with anticancer properties.
• It details their mechanisms of action on nuclear and cellular factors in carcinogenesis.
• Druggability and clinical development of these anticancer phytomolecules are also discussed.

Key Points:

• Bioactive phytochemicals exhibit selective toxicity towards cancer cells, sparing normal cells.
• Their pleiotropic functions allow them to target multiple signaling pathways involved in carcinogenesis.
• Numerous phytochemicals demonstrate anticancer activity in both in vitro and in vivo studies.

Conclusions:

• Phytochemicals represent a viable source for developing novel, side-effect-free anticancer drugs.
• Understanding their mechanisms of action is crucial for advancing their clinical application.
• Further research into druggability and clinical trials will facilitate the translation of these natural compounds into cancer therapies.